Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Environ Manage ; 366: 121728, 2024 Jul 10.
Article in English | MEDLINE | ID: mdl-38991334

ABSTRACT

This study develops environmentally benign capping technique to synthesize nanoparticles of Curcuma longa-coated titanium dioxide (CR-TiO2) from titanium isopropoxide by utilizing the extract of Rosa rubiginosa flowers as reducing and chelating agent. The biogenically synthesized nanoparticles revealed excellent anti-bacterial, electrochemical, and photocatalytic properties due to the presence of porous TiO2 nanostructures. The sharp peaks by XRD pattern showed the crystallinity and phase purity of TiO2 nanoparticles. BET analysis proved mesoporous nature of the materials with specific surface area of 134 m2 g -1. The vibrational spectra suggest hydroxyl groups from flavonoids of Curcuma longa acting as functionalizing agent for TiO2 nanoporous structures with visible luminescence, which is proven in fluorescence spectra and is applicable for photocatalytic studies. The anti-bacterial studies showed good inference on TiO2 nanoparticles against Pseudomonas auruginosa and proved it to be an excellent antipseudomonal agent with the oxidative potential. The maximum degradation of phenol red dye in the presence of TiO2 under visible light conditions was observed. The supercapacitor fabricated using the biogenic TiO2 three-electrode system exhibited a specific capacitance of 128 Fg-1 (10 mV s-1), suggesting it as an excellent electrode material. The LSV curve at 50 mV s-1 scan rate showed that oxygen reduction potential (ORR) of CR-TiO2 electrodes was 121 mV. The present study is a new application of nanoparticles in sustainability consideration of the environment as well as a solution to the power crisis with fewer limitations. The well-distinguished antidiabetic and BSA denaturation potential suggests that these porous TiO2 nanostructures can be useful for drug delivery as glucose inhibitors and oral anti-inflammatory drugs with the restriction of adverse side effects.

SELECTION OF CITATIONS
SEARCH DETAIL
...